Veklury® (remdesivir)

Handling and Precautions

This document is in response to your request for information regarding Veklury® (remdesivir [RDV]) handling and precautions.

Some data may be outside of the US FDA-approved prescribing information. In providing this data, Gilead Sciences, Inc. is not making any representation as to its clinical relevance or to the use of any Gilead product(s). For information about the approved conditions of use of any Gilead drug product, please consult the FDA-approved prescribing information.

The full indication, important safety information, and boxed warnings are available at:
www.gilead.com/-/media/files/pdfs/medicines/covid-19/veklury/veklury_pi.

RDV Handling and Precautions1

RDV is not considered a hazardous drug as defined by National Institute for Occupational Safety and Health (NIOSH) and American Society of Health System Pharmacists (ASHP) hazard classification systems. RDV can be prepared in a standard pharmacy setting. A clean room, fume hood, or laminar flow clean bench is not required for the preparation of RDV. Standard personal protective equipment (PPE) including disposable gloves and lab coat should be used for handling and administering RDV. Aseptic technique should be used where appropriate during handling, preparation, and administration.

Disposal

Any unused medicinal product or waste material should be disposed of in accordance with local requirements. Follow applicable procedures and policies for pharmaceutical waste disposal for materials contaminated with RDV.

Breakage of glass vials containing RDV

Suitable PPE, including disposable chemical resistant gloves, should be worn during cleanup. Surround the spill or powder with absorbents and cover the area with a damp cloth or towel. Add excess liquid to spilled powder to minimize entry of powder into the air. Place spill materials into leak-proof container for disposal in accordance with applicable pharmaceutical waste disposal regulations. Decontaminate the area twice with water and detergent solution. Do not attempt to pick up broken glass with hands. Use forceps, tweezers, or other suitable tools for cleanup of broken glass.

Spillage of solutions containing RDV

Standard PPE, including disposable gloves and lab coat, should be worn during cleanup. Remove any visible spillage with clean, dry paper towels. Place spill materials into leak‑proof container for disposal in accordance with applicable pharmaceutical waste disposal regulations. Clean the affected area twice with water, followed by one cleaning with a suitable detergent solution.

Reference

1. Gilead Sciences Inc. Data on File.

Product Label

For the full indication, important safety information, and boxed warning(s), please refer to the Veklury US prescribing information available at:
www.gilead.com/-/media/files/pdfs/medicines/covid-19/veklury/veklury_pi.

Follow-Up

For any additional questions, please contact Gilead Medical Information at:

☎1‐866‐MEDI‐GSI (1‐866‐633‐4474) or   www.askgileadmedical.com

Adverse Event Reporting

Please report all adverse events to:

Gilead Global Patient Safety ☎ 1-800-445-3235, option 3 or
 www.gilead.com/utility/contact/report-an-adverse-event

FDA MedWatch Program by ☎ 1-800-FDA-1088 or MedWatch, FDA, 5600 Fishers Ln, Rockville, MD 20852 or   www.accessdata.fda.gov/scripts/medwatch

Data Privacy

The Medical Information service at Gilead Sciences may collect, store, and use your personal information to provide a response to your medical request. We may share your information with other Gilead Sciences colleagues to ensure that your request is addressed appropriately. If you report an adverse event or concern about the quality of a Gilead or Kite product, we will need to use the information you have given us in order to meet our regulatory requirements in relation to the safety of our medicines.

It may be necessary for us to share your information with Gilead’s affiliates, business partners, service providers, and regulatory authorities located in countries besides your own. Gilead Sciences has implemented measures to protect the personal information you provide. Please see the Gilead Privacy Statement (www.gilead.com/privacy-statements) for more information about how Gilead handles your personal information and your rights. If you have any further questions about the use of your personal information, please contact privacy@gilead.com.

VEKLURY, GILEAD, and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or its related companies.
© 2025 Gilead Sciences, Inc.